Status:
COMPLETED
Detection of Coronary Vulnerable Plaque With Contrast-enhanced Magnetic Resonance Imaging
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Bayer
Conditions:
Coronary Artery Disease
Stable Angina
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
MRI has the ability to visualize the arterial vessel wall. Wall thickening and atherosclerotic plaque components can be visualized in the carotid arteries and the aorta. Previous studies also demonstr...
Eligibility Criteria
Inclusion
- scheduled X-ray angiography for known coronary artery disease, valvular disease or chest pain with unknown origin
- age \> 18 yrs and \< 90 yrs
- Informed consent
Exclusion
- arrhythmia
- hemodynamic unstable patients
- contra-indications for (contrast-enhanced) MRI
- age \< 18 yrs or \> 90 yrs
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00984776
Start Date
March 1 2007
Last Update
September 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Netherlands, 6229 HX